Search for: "STEVENS V US"
Results 181 - 200
of 6,736
Sort by Relevance
|
Sort by Date
19 Sep 2023, 8:32 am
Wyeth LLC v. [read post]
12 Sep 2023, 7:35 pm
In particular, here is the summary of Part V, which focuses on the office issue: Part V considers another threshold question: was Trump ever subject to Section 3? [read post]
11 Sep 2023, 9:01 pm
As the Supreme Court stated in the 1868 case of Texas v. [read post]
11 Sep 2023, 6:37 am
The chain of events leading to the reasonable accommodation denial in Oross v. [read post]
7 Sep 2023, 7:23 am
Stevens v. [read post]
4 Sep 2023, 8:00 am
Rossignol v. [read post]
1 Sep 2023, 7:06 am
at n.104 (quoting Stevens v. [read post]
30 Aug 2023, 3:25 pm
The case is Thaler v. [read post]
30 Aug 2023, 12:55 pm
The opinion is today's dissent from denial of rehearing en banc in U.S. v. [read post]
29 Aug 2023, 9:01 pm
In Regents of Univ. of California v. [read post]
26 Aug 2023, 9:16 am
Protective letters In the case MyStromer v Revolt Zycling (UPC_CFI_177/2023) the UPC’s local division in Düsseldorf ordered a preliminary injunction, despite the fact that Revolt had filed a protective letter. [read post]
25 Aug 2023, 6:22 pm
Dec. 6, 2022); see also Horwin v. [read post]
How Jack Smith May Charge Trump PAC with Fraudulent Fundraising Within the Bounds of First Amendment
24 Aug 2023, 5:55 am
Stevens, (2010) (citations and internal quotation marks omitted)). [read post]
16 Aug 2023, 8:22 am
Longarzo * DMCA’s Unhelpful 512(f) Preempts Helpful State Law Claims–Stevens v. [read post]
14 Aug 2023, 5:36 am
This duo gives us a solid overview of the MQD’s triggers that is increasingly being picked up by advocates and academics. [read post]
13 Aug 2023, 4:53 am
Steven McCraw, et. [read post]
9 Aug 2023, 5:00 am
In the case of Harrigan v. [read post]
7 Aug 2023, 9:12 pm
In Brown Shoe v. [read post]
3 Aug 2023, 4:00 am
Delta Air Lines, Zicherman v. [read post]
2 Aug 2023, 2:14 am
On 25 July 2023, the Court of Appeal handed down its decision in Teva & Sandoz v Astellas[1] concerning the validity of Astellas’ patent to mirabegron for use in the treatment of overactive bladder (“OAB”). [read post]
